AKOS CZIBERE

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return 13% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
AKOS CZIBERE's trades of Aktis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
69.56
Quantity 98,281 +0.8%
Value US$972,213
Transaction date
Planned sale
Price
358.11
Quantity 17,227 +12.5%
Value US$3,083,138
Transaction date
Proposed sale
Price
305.08
Quantity 20,316
Value US$3,572,896
Transaction date
Sale
Price
28.71
Quantity 4,371 -100.0%
Value US$125,482
Transaction date
Sale
Price
27.95
Quantity 30,829 -87.6%
Value US$861,735
Transaction date
Sale
Price
27.13
Quantity 14,800 -29.6%
Value US$401,484
Transaction date
Proposed sale
Price
27.77
Quantity 50,000
Value US$1,388,700
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-24 2026-09-23
PlS Planned sale
98,281 +0.8%
69.56
US$972,213 		98,281 +0.8% 69.56 US$972,213
2026-09-24 2026-09-23
PlS Planned sale
17,227 +12.5%
358.11
US$3,083,138 		17,227 +12.5% 358.11 US$3,083,138
2026-09-23 2026-09-23
PrS Proposed sale
20,316
305.08
US$3,572,896 		20,316 305.08 US$3,572,896
2026-07-10 2026-07-08
S Sale
4,371 -100.0%
28.71
US$125,482 		4,371 -100.0% 28.71 US$125,482
2026-07-10 2026-07-08
S Sale
30,829 -87.6%
27.95
US$861,735 		30,829 -87.6% 27.95 US$861,735
2026-07-10 2026-07-08
S Sale
14,800 -29.6%
27.13
US$401,484 		14,800 -29.6% 27.13 US$401,484
2026-07-08 2026-07-08
PrS Proposed sale
50,000
27.77
US$1,388,700 		50,000 27.77 US$1,388,700